J. Anthony Child - Concepedia

Author

J. Anthony Child

Also Known As

J A Child, J Anthony Child, J. A. CHILD, J. A. Child, J. Anthony Child, J. Child, J.A Child, J.A. CHILD, J.A. Child, JA Child

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University of Leeds Institute of Cancer Research Newcastle University University of Birmingham St James's University Hospital

About

J. Anthony Child is an author at University of Leeds specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.8K
2	Health Sciences	6	6	488
3	Immunology	3	3	277
4	Cell Biology	2	2	97
5	Emergency Medicine	1	1	19

J. Anthony Child

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, The Lancet Hematological MalignancyZoledronic AcidOncologyPharmacologyHematology	2010	566
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation Brian G.M. Durie, Robert A. Kyle, Andrew R. Belch, The Hematology Journal International Myeloma FoundationHematological MalignancyOncologyHematologyConsensus Report	2003	423
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial Kevin Boyd, F. M. Ross, Laura Chiecchio, Leukemia Hematological MalignancyNovel Prognostic ModelMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2011	344
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis Gareth J. Morgan, Walter M. Gregory, Faith E. Davies, Blood	2011	329
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation Andy C. Rawstron, Faith E. Davies, Ranjit Dasgupta, Blood	2002	209
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Blood	2011	192
Colonic Dendritic Cells, Intestinal Inflammation, and T Cell-Mediated Bone Destruction Are Modulated by Recombinant Osteoprotegerin A. John Ashcroft, Sheena Cruickshank, Peter I. Croucher, Immunity InflammationSclerostinAutoimmune DiseaseIntestinal InflammationBone Morphogenic Protein	2003	180
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial Gareth J. Morgan, J. Anthony Child, Walter M. Gregory, The Lancet Oncology	2011	161
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Haematologica	2011	159
Long-term Follow-up of MRC Myeloma IX Trial: Survival Outcomes with Bisphosphonate and Thalidomide Treatment Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Clinical Cancer Research	2013	151

Page 1